History
Polyneuropathy is a concept closer to a "cluster of symptoms" arising when the body's peripheral nerves (peripheral nervous system, PNS) are damaged together at multiple sites, rather than the name of a single disease. In the past, even when there were symptoms such as numbness or burning in the hands and feet or muscle weakness, it was difficult to classify the causes precisely, so they were often lumped together and described as "the nerves have become weak." However, as nerve anatomy and pathology, as well as electrophysiological testing methods such as nerve conduction studies (NCS) and electromyography (EMG), advanced, a framework became established for classifying the pattern of damage as axonal or demyelinating, sensory-predominant or motor-predominant, and acute or chronic.
This classification is not merely an academic distinction; it is central to explaining to actual patients "why these symptoms occur" and "what tests are needed and whether treatment is possible."
Recent research emphasizes an approach that does not simply "look for the cause" of peripheral neuropathy, but combines the timing of onset (acute/chronic), distribution (whether length-dependent), and accompanying systemic symptoms (weight loss, fever, signs of autoimmune disease, etc.) to quickly screen for the possibility of a "treatable neuropathy."
Causes
The causes of polyneuropathy are very diverse, and they are easiest to understand when broadly divided into "metabolic and endocrine," "nutritional deficiency," "drugs and toxins," "immune and inflammatory," "infectious," "hereditary," and "other systemic diseases." The most commonly mentioned cause is peripheral neuropathy related to diabetes mellitus (DM), and when blood sugar control is poor for a long time, both the microvessels that supply nutrients to the nerves and the nerves themselves can be damaged. Causes such as vitamin B12 deficiency and alcohol use disorder (AUD) are also mentioned relatively often.
Drugs and toxins are also important causes. A typical example is numbness in the hands and feet that lasts a long time after chemotherapy, and certain drugs can damage axons through neurotoxicity. Immune and inflammatory causes include acutely progressing forms such as Guillain-Barré syndrome (GBS), as well as forms such as chronic inflammatory demyelinating polyneuropathy (CIDP), which progress over weeks to months and may respond to immunotherapy.
Recent research emphasizes that even when a case begins as "idiopathic," with no apparent cause, it is not uncommon for the cause to be revealed later as other symptoms appear over time or as testing techniques (especially genetic testing) advance. Rather than determining the cause all at once, it is safer to narrow it down by synthesizing the symptom pattern, accompanying diseases, medications being taken, lifestyle habits, and test results.
Genetic Epidemiology
Genetic epidemiology deals with "how much genetic factors are involved in polyneuropathy and in what form they appear." Polyneuropathy commonly arises from acquired causes (diabetes, drugs, nutritional deficiency, etc.), but in some cases the cause is a disease in which the nerves are congenitally weak, such as hereditary peripheral neuropathy (e.g., Charcot-Marie-Tooth disease, CMT). Such hereditary diseases may begin at a relatively young age or be accompanied by characteristic findings such as changes in foot shape (high arches, pes cavus) and hammer toes.
The key to heredity is not that "having one gene means it will definitely occur," but that particular genetic variants create a vulnerability in the structure and maintenance of nerves, and over time problems become apparent starting with the longest nerves.
Recent research concludes that some cases that initially appear to be sensory-predominant polyneuropathy of unknown cause may have a hereditary cause revealed through more precise genetic analysis. Family history and physical findings can be hints, but it may also not be safe to conclude that "it is not hereditary because there is no family history."
General Epidemiology
Polyneuropathy belongs to a group of symptoms that is fairly common in the overall population, but the exact prevalence varies depending on the cause and diagnostic criteria. The most common form in clinical practice is "length-dependent distal symmetric polyneuropathy," which, as the name suggests, is a pattern in which symptoms begin in the longest and most distal nerves (toes, fingertips) and appear similarly on both sides. It becomes more common with age and may appear more readily when there are accompanying diseases such as diabetes or chronic kidney disease.
Just because the symptoms are common does not mean they can be taken lightly. When sensation in the hands and feet becomes dulled, the risk of falls increases, wounds on the feet may be noticed late and develop into ulcers, and when pain is severe, sleep and daily functioning decline significantly. In addition, when autonomic nerve involvement accompanies it, discomforts affecting daily life as a whole can arise, such as dizziness (orthostatic hypotension), indigestion, abnormal sweating, and sexual function problems.
Pathogenesis
Pathogenesis explains "in what way the nerves are damaged." Peripheral nerves consist of axons, which transmit signals like electrical wires, and the myelin sheath, which surrounds those wires and acts as an insulator so that electrical signals flow quickly and accurately. Polyneuropathy can be explained mainly within three broad frameworks: axonopathy, in which the axons gradually break down (distal axonopathy); demyelinating neuropathy, in which the myelin sheath is damaged (myelinopathy); and neuronopathy, in which the nerve cell bodies themselves are damaged.
Diabetes, alcohol, nutritional deficiency, drugs and toxins, and similar causes commonly take a form that "weakens the axons starting from their ends," which explains the pattern in which numbness and reduced sensation begin in distant areas such as the toes. In contrast, in diseases such as CIDP, in which the immune system works in the wrong direction, the myelin sheath is attacked, so nerve conduction velocity may slow and muscle weakness may be relatively prominent.
Recent research emphasizes that in sensory-predominant polyneuropathy, the pain pattern, autonomic symptoms, and choice of tests may differ depending on whether the large fibers (thick nerve fibers) or the small fibers (thin nerve fibers) are more damaged. Identifying the type of damage is the key to determining the correct diagnosis and treatment direction.
Symptoms
The representative symptoms of polyneuropathy are numbness, reduced sensation, burning (burning pain), and tingling pain in the hands and feet. They usually show a distribution described as a "stocking-glove pattern," starting in the toes and rising toward the calves. When sensation in the soles becomes dull, it is sometimes described as "feeling like walking on thick paper," and people with severe pain may complain that it hurts even when the blanket merely brushes against them.
When the motor nerves are also involved, ankle strength may weaken so that the foot drags (foot drop), or climbing stairs may become difficult. When sensation and muscle strength decline at the same time, the sense of balance worsens, causing more unsteadiness in dark places and increasing the risk of falls. When there is autonomic nerve involvement, various discomforts may appear, such as dizziness on standing up, alternating diarrhea and constipation, or abnormal sweating.
Recent research emphasizes that sensory-predominant distal sensory polyneuropathy (DSP) is very common, and that although the cause is often not found at first, it is sometimes revealed during follow-up. Therefore, rather than attributing the symptoms only to "age," a basic evaluation to find the cause is important.
Signs
Representative signs confirmed on examination include reduced sensation in the toes and fingertips (pain, temperature, and vibration sense), decreased ankle reflexes (reduced Achilles tendon reflex), unsteady gait, and weakness of the toes and ankles. Reduced sensation tends to start at the tips of the toes and gradually rise upward, so it is helpful to identify "the boundary line where sensation is reduced" on examination.
In hereditary neuropathy, structural changes of the feet (high arches, pes cavus), hammer toes, and atrophy of the distal leg muscles may be observed. In long-standing polyneuropathy, the small muscles of the feet may atrophy and change the shape of the feet, or the small muscles of the hands may atrophy, making fine hand movements difficult.
When autonomic nerve involvement is suspected, clues such as changes in blood pressure on standing, dry skin and abnormal sweat distribution, and changes in pulse may be seen together. These signs go beyond simply aiding diagnosis; they play an important role in determining the direction of treatment by identifying which nerve fibers are damaged and to what extent.
Screening
Polyneuropathy is not a group of diseases for which "a single screening test targeting the general population" has been established. Instead, realistic screening is carried out by detecting reduced sensation in the feet early in risk groups (especially diabetes, chronic drinking, possible nutritional deficiency, history of chemotherapy, etc.). At a level that the general public can check on their own, the first step is to check whether sensation in the toes has become duller than before, whether heat and cold are not felt well, whether wounds or blisters are noticed late, and whether one wakes at night because of numbness or burning.
In the clinic, methods such as a simple tool for checking the protective sensation of the feet (monofilament) and checking vibration sense with a 128 Hz tuning fork are widely used. This step is closer to the role of determining "whether further evaluation is needed" than to "confirming the diagnosis."
Recent research concludes that an approach that structures the timing of onset and distribution of symptoms and the presence of accompanying systemic symptoms is useful for detecting the possibility of inflammatory (treatable) neuropathy more quickly. In particular, if it progresses rapidly or is accompanied by weakness in the limbs on both sides, it is important to receive a specialist evaluation immediately.
Diagnosis
Diagnosis is easiest to understand in three broad steps. First, through the medical history and neurological examination, it is determined "whether it is truly a polyneuropathy pattern," "whether it is closest to acute, subacute, or chronic," "whether it is sensory-predominant or motor-predominant," and "whether it is length-dependent and symmetric or asymmetric and focal." Second, basic blood tests to find the cause are performed. In actual clinical practice, it is common to first check "causes that must not be missed," such as blood glucose and glycated hemoglobin, vitamin B12, thyroid function, kidney and liver function, and serum protein electrophoresis (SPEP).
Third, the type of damage is classified with nerve conduction studies (NCS) and electromyography (EMG). If demyelinating findings are evident here, immune diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP) are suspected more actively, and if axonal findings predominate, the cause is narrowed down with a focus on diabetes, toxins, nutritional deficiency, heredity, and so on. When small fiber neuropathy is suspected, standard NCS may be normal, so skin biopsy (evaluation of intraepidermal nerve fiber density) or autonomic testing may be considered depending on the symptoms and examination findings.
Recent research emphasizes a strategy of broadening the diagnostic workup so as not to miss "treatable causes" when the onset is rapid, muscle weakness is prominent, systemic symptoms accompany it, or it is asymmetric, even if the cause is not immediately clear.
Treatment
The principle of treatment is "treatment of the cause + treatment of symptoms + prevention of complications." Treatment of the cause is most important where possible. For example, if diabetes is the cause, blood sugar control is optimized; if a vitamin deficiency is confirmed, it is supplemented; and if there is a drug suspected of neurotoxicity, it is adjusted in consultation with the attending physician. If an immune-mediated demyelinating neuropathy (such as CIDP) is suspected or confirmed, treatments such as intravenous immunoglobulin (IVIG), steroids, and plasma exchange (PLEX) may be discussed.
In symptom treatment, pain control accounts for a large share. Because general analgesics alone are often insufficient for neuropathic pain, drugs for controlling neuralgia (e.g., gabapentinoids / duloxetine, etc.) are used depending on the situation. In addition, if there is reduced balance or muscle strength, rehabilitation, walking aids, occupational therapy, and the like substantially help reduce falls and functional decline.
Recent research emphasizes that, because distal sensory polyneuropathy (DSP) has diverse causes and is not easy to diagnose, standardized assessment measures should be created and treatment response and natural history should be better understood through long-term follow-up. It is good to understand this not as meaning "there is no treatment," but as meaning that tailored treatment matched to the cause and type is important.
Prognosis
The prognosis varies greatly depending on the cause, the type of damage, and whether treatment is possible. When axonal damage predominates, as with diabetes, alcohol, or nutritional deficiency, recovery may be slow or incomplete even if the cause is corrected, but the goals of slowing progression and reducing pain and complications are still well worthwhile. Conversely, in cases where a treatment response is possible, such as immune-mediated demyelinating neuropathy, there is greater room for functional recovery if it is diagnosed early and appropriate immunotherapy is started.
Important prognostic factors in daily life are "foot complications due to reduced sensation" and "falls due to reduced balance." When sensation is dulled, wounds may be discovered late and lead to infection and ulcers, and especially in people with diabetes, foot care directly affects the prognosis. Because sleep disorders, depression, and anxiety sometimes accompany severe pain, it is realistic to evaluate the prognosis including not only nerve function but also quality of life (QOL).
Recent research concludes that, because even among DSP cases initially classified as idiopathic there are cases in which the cause is revealed over time or a genetic cause comes to light, follow-up observation and reevaluation over a certain period are needed. Early detection and consistent management have the greatest influence on the long-term prognosis.
Prevention
There is no single method that completely prevents polyneuropathy all at once. This is because the causes are so diverse. Instead, it is helpful to think about the "preventable parts" step by step. First, regarding diabetes, one of the most common causes, managing metabolic health through blood sugar control, weight management, regular exercise, and quitting smoking is important for reducing the risk of nerve damage. Second, to prevent nutritional deficiency, a balanced diet and, where necessary, checking vitamin status can be helpful. Third, it is important to reduce excessive alcohol intake and, if taking a drug known to be neurotoxic, to consult the medical team early when symptoms develop.
In addition, "preventing complications" is a very practical method of prevention. People with reduced sensation in their feet can reduce ulcers and infections by examining their feet every day, wearing well-fitting shoes, and getting prompt treatment when wounds or blisters develop. If balance has worsened, it is good to lower the risk of falls by organizing the home environment and, if necessary, to make use of a cane, orthoses, and rehabilitation.
Ultimately, the core of prevention can be summarized as "a lifestyle strategy that lowers the risk from causes and detects the condition early to reduce progression and complications." If symptoms are already present, the most realistic prevention is not to put them off as "due to age," but to find the cause and begin appropriate management.